Age-specific administration of chemotherapy and long-Term quality of life in stage II and III colorectal cancer patients: A population-based prospective cohort

Oncologist

Volumn 16, Issue 12, 2011, Pages 1741-1751

  Jansen, Lina ^a   Hoffmeister, Michael ^a   Chang Claude, Jenny ^a   Koch, Moritz ^b   Brenner, Hermann ^a   Arndt, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer survivors; Chemotherapy; Colorectal cancer; Long term; Quality of life; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGE; AGED; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVOR; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SURVIVAL TIME; TASTE; XEROSTOMIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84855171744     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0124     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available at http://globocan.iarc.fr, accessed April 7, 2011.
2. Schmiegel W, Reinacher-Schick A, Arnold D et al. [Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol 2008;46:799-840.
3. Gray R, Barnwell J, McConkey C et al.; Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 2007;370:2020-2029.
4. Jansen L, Koch L, Brenner H et al. Quality of life among long-term (≥5 years) colorectal cancer survivors-systematic review. Eur J Cancer 2010; 46:2879-2888.
5. Arndt V, Merx H, Stegmaier C et al. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis:Apopulation based study. Eur J Cancer 2006;42:1848-1857.
6. Anthony T, Jones C, Antoine J et al. The effect of treatment for colorectal cancer on long-term health-related quality of life. Ann Surg Oncol 2001; 8:44-49.
7. Bouvier AM, Jooste V, Bonnetain F et al. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: A population-based study. Cancer 2008;113:879-886.
8. Ahles TA, Saykin AJ, Furstenberg CT et al. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol 2005;23: 4399-4405.
9. Mols F, Vingerhoets AJ, Coebergh JW et al. Quality of life among long-term breast cancer survivors: A systematic review. Eur J Cancer 2005;41: 2613-2619.
10. Brenner H, Arndt V. Cancer among older adults: Incidence, prognosis and new avenues of prevention. In: Wahl HW, Brenner H, Mollenkopf H et al., eds. The Many Faces of Health, Competence and Well-Being in Old Age. Dordrecht, The Netherlands: Springer, 2006;139-151.
11. Gondos A, Arndt V, Holleczek B et al. Cancer survival in Germany and the United States at the beginning of the 21st century: An up-to-date comparison by period analysis. Int J Cancer 2007;121:395-400.
12. Brenner H, Chang-Claude J, Seiler CM et al. Protection from colorectal cancer after colonoscopy: A population-based, case-control study. Ann Intern Med 2011;154:22-30.
13. Hoffmeister M, Raum E, Krtschil A et al. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clin Pharmacol Ther 2009;86: 416-424.
14. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
15. Gujral S, Conroy T, Fleissner C et al. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire. Eur J Cancer 2007;43:1564-1573.
16. Whistance RN, Conroy T, Chie W et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess healthrelated quality of life in patients with colorectal cancer. Eur J Cancer 2009;45:3017-3026.
17. Fayers P, Aaronson NK, Bjordal K et al. The EORTC QLQ-C30 scoring manual. Brussels, Belgium: European Organization for Research and Treatment of Cancer, 1999:1-78.
18. Osoba D, Rodrigues G, Myles J et al. Inter-preting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-144.
19. Craig CL, Marshall AL, Sjöstrom M et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
20. Balducci L. Management of cancer in the elderly. Oncology (Williston Park) 2006;20:135-143; discussion 144, 146, 151-152.
21. Foster JA, Salinas GD, Mansell D et al. How does older age influence oncologists' cancer management? The Oncologist 2010;15:584-592.
22. Burdette-Radoux S, Muss HB. Adjuvant chemotherapy in the elderly: Whom to treat, what regimen? The Oncologist 2006;11:234-242.
23. Schrag D, Cramer LD, Bach PB et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-857.
24. Hutchins LF, Unger JM, Crowley JJ et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. NEngl J Med 1999; 341:2061-2067.
25. Popescu RA, Norman A, Ross PJ et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 1999; 17:2412-2418.
26. Wefel JS, Saleeba AK, BuzdarAUet al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010;116:3348-3356.
27. Wenzel LB, Fairclough DL, Brady MJ et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 1999;86:1768-1774.
28. Avis NE, Deimling GT. Cancer survivorship and aging. Cancer 2008;113(12 suppl): 3519-3529.
29. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
30. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004;22:1797-1806.